Overexpression of miR125b Promotes Osteoporosis Through miR-125b-TRAF6 Pathway in Postmenopausal Ovariectomized Rats

Area of Science:

• Molecular Biology
• Biomedical Research
• Genetics

Background:

• Postmenopausal osteoporosis is a prevalent condition in women, yet molecular mechanisms for targeted therapies remain underexplored.
• This study focuses on elucidating the specific role of microRNA-125b (miR-125b) in the pathogenesis of postmenopausal osteoporosis.

Purpose of the Study:

• To investigate the role and mechanism of miR-125b in postmenopausal osteoporosis.
• To identify potential therapeutic targets for managing this condition.

Main Methods:

• Microarray analysis and miRNA profiling of postmenopausal osteoporosis tissues.
• In vitro studies using MC3T3-E1 cells to assess cell viability, toxicity, and gene expression.
• Bioinformatic analysis and luciferase reporter assays to identify and confirm miR-125b targets.
• Ovariectomized rat model to evaluate the in vivo effects of miR-125b on bone mineral density, biomechanics, and molecular pathways (JAK2/STAT3).

Main Results:

• miR-125b was significantly over-expressed in human osteoporosis samples.
• In vitro, miR-125b suppressed cell viability, increased RANKL/OPG ratio, and reduced BMP2 and Runx2 levels.
• miR-125b targets TRAF6, negatively regulating its expression via the JAK2/STAT3 pathway, leading to decreased bone mineral density and biomechanical strength in a rat model.

Conclusions:

• miR-125b plays a critical role in the development and progression of postmenopausal osteoporosis.
• The TRAF6 gene, modulated through the JAK2/STAT3 pathway, is a key mediator of miR-125b's osteoporotic effects.